1. Home
  2. AVDL vs MXL Comparison

AVDL vs MXL Comparison

Compare AVDL & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • MXL
  • Stock Information
  • Founded
  • AVDL 2015
  • MXL 2003
  • Country
  • AVDL Ireland
  • MXL United States
  • Employees
  • AVDL N/A
  • MXL N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • MXL Semiconductors
  • Sector
  • AVDL Health Care
  • MXL Technology
  • Exchange
  • AVDL Nasdaq
  • MXL Nasdaq
  • Market Cap
  • AVDL 1.4B
  • MXL 1.5B
  • IPO Year
  • AVDL 1996
  • MXL 2010
  • Fundamental
  • Price
  • AVDL $15.66
  • MXL $16.16
  • Analyst Decision
  • AVDL Strong Buy
  • MXL Buy
  • Analyst Count
  • AVDL 8
  • MXL 8
  • Target Price
  • AVDL $20.88
  • MXL $20.93
  • AVG Volume (30 Days)
  • AVDL 1.5M
  • MXL 1.4M
  • Earning Date
  • AVDL 11-11-2025
  • MXL 10-22-2025
  • Dividend Yield
  • AVDL N/A
  • MXL N/A
  • EPS Growth
  • AVDL N/A
  • MXL N/A
  • EPS
  • AVDL N/A
  • MXL N/A
  • Revenue
  • AVDL $221,075,000.00
  • MXL $378,015,000.00
  • Revenue This Year
  • AVDL $64.56
  • MXL $28.85
  • Revenue Next Year
  • AVDL $30.60
  • MXL $17.69
  • P/E Ratio
  • AVDL N/A
  • MXL N/A
  • Revenue Growth
  • AVDL 132.35
  • MXL N/A
  • 52 Week Low
  • AVDL $6.38
  • MXL $8.35
  • 52 Week High
  • AVDL $16.66
  • MXL $25.73
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 65.57
  • MXL 53.32
  • Support Level
  • AVDL $14.78
  • MXL $15.51
  • Resistance Level
  • AVDL $16.04
  • MXL $17.04
  • Average True Range (ATR)
  • AVDL 0.57
  • MXL 0.69
  • MACD
  • AVDL -0.11
  • MXL 0.01
  • Stochastic Oscillator
  • AVDL 79.23
  • MXL 56.00

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

Share on Social Networks: